Contact Information
Call us at: (614) 722-3250
Fax us at: (614) 722-8826
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Ralph Salloum
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Research
Interests
Developmental Therapeutics Early Phase Clinical Trials Late Effects of CNS Tumors
Publications
Erker C, Mynarek M, Bailey S, Mazewski CM, Baroni L, Massimino M, Hukin J, Aguilera D, Cappellano AM, Ramaswamy V, Lassaletta A, Perreault S, Kline CN, Rajagopal R, Michaiel G, Zapotocky M, Santa-Maria Lopez V, La Madrid AM, Cacciotti C, Sandler ES, Hoffman LM, Klawinski D, Khan S, Salloum R, Hoppmann AL, Larouche V, Dorris K, Toledano H, Gilheeney SW, Abdelbaki MS, Wilson B, Tsang DS, Knipstein J, Oren MY, Shah S, Murray JC, Ginn KF, Wang ZJ, Fleischhack G, Obrecht D, Tonn S, Harrod VL, Matheson K, Crooks B, Strother DR, Cohen KJ, Hansford JR, Mueller S, Margol A, Gajjar A, Dhall G, Finlay JL, Northcott PA, Rutkowski S, Clifford SC, Robinson G, Bouffet E, Lafay-Cousin L. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. J Clin Oncol. 2022 Dec 22; JCO2102968.
Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;
Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;
DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. Front Oncol. 2022; 12: 893855.
Ronsley R, Boué DR, Venkata LPR, Scott S, Shaikhouni A, Jones J, Schieffer KM, Cottrell CE, Mardis ER, Olshefski R, Salloum R, Miller KE. An unusual case of atypical teratoid/rhabdoid tumor, initially diagnosed as atypical pituitary adenoma in a 13-year-old male patient. Neurooncol Adv. 2022 Jan-Dec; 4: vdac121.
Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.
Fisher AP, Patronick J, Gerhardt CA, Radonovich K, Salloum R, Wade SL. Impact of COVID-19 on adolescent and emerging adult brain tumor survivors and their parents. Pediatr Blood Cancer. 2021 Sep; 68: e29116.
McGrady ME, Bredenberg DL, Danziger-Isakov L, Rios J, Frias O, West MY, Fisher P, Salloum R, Pressey JG, Norris RE. Active and Protected: Developing a "Safer Sex" Handout for Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2021 Jun; 10: 351-354.
Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.
Moscato EL, Fisher AP, Gies LM, Smith-Paine JM, Miley AE, Beebe DW, Quinton TL, Pai ALH, Salloum R, Wade SL. A Mixed-Methods Analysis of Family Perceptions of Neuropsychological Evaluation and Resources for Pediatric Brain Tumor Survivors. Arch Clin Neuropsychol. 2021 Mar 24;
DeWire M, Erker C, Hummel TR, Chow LML, de Blank P, Salloum R, Pillay-Smiley N, Hoffman L, Gilger E, Gallagher M, Driver L, Meister D, Ward H, Drissi R, Kumar SS, Sengupta S, Kikta B, Meriwether W, Jelinek S, Asher A, Jones B, Leach J, Miles L, Fuller C, Fouladi M. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. J Neurooncol. 2021 Mar; 152: 107-114.
Martinez HR, Salloum R, Wright E, Bueche L, Khoury PR, Tretter JT, Ryan TD. Echocardiographic myocardial strain analysis describes subclinical cardiac dysfunction after craniospinal irradiation in pediatric and young adult patients with central nervous system tumors. Cardiooncology. 2021 Feb 2; 7: 5.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 11/09/2020
Board Certifications
Internal Medicine Pediatric Hematology Oncology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2015
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2014
Residency
Detroit Medical Center
Date Completed: 06/15/2011
Medical School
American University of Beruit
Date Completed: 06/09/2006
Clinical Interests
Adolescent and Young Adult Oncology Brain Tumor Survivorship Pediatric Neuro-oncology
Contact Information
Pediatrics
Call us at: (614) 722-3250
Fax us at: (614) 722-8826
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-3250
Fax us at: (614) 722-8826
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Ralph Salloum
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Research
Interests
Developmental Therapeutics Early Phase Clinical Trials Late Effects of CNS Tumors
Publications
Erker C, Mynarek M, Bailey S, Mazewski CM, Baroni L, Massimino M, Hukin J, Aguilera D, Cappellano AM, Ramaswamy V, Lassaletta A, Perreault S, Kline CN, Rajagopal R, Michaiel G, Zapotocky M, Santa-Maria Lopez V, La Madrid AM, Cacciotti C, Sandler ES, Hoffman LM, Klawinski D, Khan S, Salloum R, Hoppmann AL, Larouche V, Dorris K, Toledano H, Gilheeney SW, Abdelbaki MS, Wilson B, Tsang DS, Knipstein J, Oren MY, Shah S, Murray JC, Ginn KF, Wang ZJ, Fleischhack G, Obrecht D, Tonn S, Harrod VL, Matheson K, Crooks B, Strother DR, Cohen KJ, Hansford JR, Mueller S, Margol A, Gajjar A, Dhall G, Finlay JL, Northcott PA, Rutkowski S, Clifford SC, Robinson G, Bouffet E, Lafay-Cousin L. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. J Clin Oncol. 2022 Dec 22; JCO2102968.
Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;
Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;
DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. Front Oncol. 2022; 12: 893855.
Ronsley R, Boué DR, Venkata LPR, Scott S, Shaikhouni A, Jones J, Schieffer KM, Cottrell CE, Mardis ER, Olshefski R, Salloum R, Miller KE. An unusual case of atypical teratoid/rhabdoid tumor, initially diagnosed as atypical pituitary adenoma in a 13-year-old male patient. Neurooncol Adv. 2022 Jan-Dec; 4: vdac121.
Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.
Fisher AP, Patronick J, Gerhardt CA, Radonovich K, Salloum R, Wade SL. Impact of COVID-19 on adolescent and emerging adult brain tumor survivors and their parents. Pediatr Blood Cancer. 2021 Sep; 68: e29116.
McGrady ME, Bredenberg DL, Danziger-Isakov L, Rios J, Frias O, West MY, Fisher P, Salloum R, Pressey JG, Norris RE. Active and Protected: Developing a "Safer Sex" Handout for Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2021 Jun; 10: 351-354.
Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.
Moscato EL, Fisher AP, Gies LM, Smith-Paine JM, Miley AE, Beebe DW, Quinton TL, Pai ALH, Salloum R, Wade SL. A Mixed-Methods Analysis of Family Perceptions of Neuropsychological Evaluation and Resources for Pediatric Brain Tumor Survivors. Arch Clin Neuropsychol. 2021 Mar 24;
DeWire M, Erker C, Hummel TR, Chow LML, de Blank P, Salloum R, Pillay-Smiley N, Hoffman L, Gilger E, Gallagher M, Driver L, Meister D, Ward H, Drissi R, Kumar SS, Sengupta S, Kikta B, Meriwether W, Jelinek S, Asher A, Jones B, Leach J, Miles L, Fuller C, Fouladi M. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. J Neurooncol. 2021 Mar; 152: 107-114.
Martinez HR, Salloum R, Wright E, Bueche L, Khoury PR, Tretter JT, Ryan TD. Echocardiographic myocardial strain analysis describes subclinical cardiac dysfunction after craniospinal irradiation in pediatric and young adult patients with central nervous system tumors. Cardiooncology. 2021 Feb 2; 7: 5.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 11/09/2020
Board Certifications
Internal Medicine Pediatric Hematology Oncology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2015
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2014
Residency
Detroit Medical Center
Date Completed: 06/15/2011
Medical School
American University of Beruit
Date Completed: 06/09/2006
Clinical Interests
Adolescent and Young Adult Oncology Brain Tumor Survivorship Pediatric Neuro-oncology
Contact Information
Pediatrics
Call us at: (614) 722-3250
Fax us at: (614) 722-8826
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-3250
Fax us at: (614) 722-8826
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Ralph Salloum
Contact Information
- Call us at:
- (614) 722-3250
- Fax us at:
- (614) 722-8826
- PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Ralph Salloum
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Academic and Clinical Areas
Hematology/Oncology & BMT
Physician Team
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Hematology/Oncology & BMT
Physician Team
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
- Hematology/Oncology & BMT
- Physician Team
- Primary Department
- Pediatrics
- Primary Section
- Hematology & Oncology
Research
Interests
Developmental Therapeutics Early Phase Clinical Trials Late Effects of CNS Tumors
Publications
Erker C, Mynarek M, Bailey S, Mazewski CM, Baroni L, Massimino M, Hukin J, Aguilera D, Cappellano AM, Ramaswamy V, Lassaletta A, Perreault S, Kline CN, Rajagopal R, Michaiel G, Zapotocky M, Santa-Maria Lopez V, La Madrid AM, Cacciotti C, Sandler ES, Hoffman LM, Klawinski D, Khan S, Salloum R, Hoppmann AL, Larouche V, Dorris K, Toledano H, Gilheeney SW, Abdelbaki MS, Wilson B, Tsang DS, Knipstein J, Oren MY, Shah S, Murray JC, Ginn KF, Wang ZJ, Fleischhack G, Obrecht D, Tonn S, Harrod VL, Matheson K, Crooks B, Strother DR, Cohen KJ, Hansford JR, Mueller S, Margol A, Gajjar A, Dhall G, Finlay JL, Northcott PA, Rutkowski S, Clifford SC, Robinson G, Bouffet E, Lafay-Cousin L. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. J Clin Oncol. 2022 Dec 22; JCO2102968.
Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;
Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;
DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. Front Oncol. 2022; 12: 893855.
Ronsley R, Boué DR, Venkata LPR, Scott S, Shaikhouni A, Jones J, Schieffer KM, Cottrell CE, Mardis ER, Olshefski R, Salloum R, Miller KE. An unusual case of atypical teratoid/rhabdoid tumor, initially diagnosed as atypical pituitary adenoma in a 13-year-old male patient. Neurooncol Adv. 2022 Jan-Dec; 4: vdac121.
Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.
Fisher AP, Patronick J, Gerhardt CA, Radonovich K, Salloum R, Wade SL. Impact of COVID-19 on adolescent and emerging adult brain tumor survivors and their parents. Pediatr Blood Cancer. 2021 Sep; 68: e29116.
McGrady ME, Bredenberg DL, Danziger-Isakov L, Rios J, Frias O, West MY, Fisher P, Salloum R, Pressey JG, Norris RE. Active and Protected: Developing a "Safer Sex" Handout for Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2021 Jun; 10: 351-354.
Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.
Moscato EL, Fisher AP, Gies LM, Smith-Paine JM, Miley AE, Beebe DW, Quinton TL, Pai ALH, Salloum R, Wade SL. A Mixed-Methods Analysis of Family Perceptions of Neuropsychological Evaluation and Resources for Pediatric Brain Tumor Survivors. Arch Clin Neuropsychol. 2021 Mar 24;
DeWire M, Erker C, Hummel TR, Chow LML, de Blank P, Salloum R, Pillay-Smiley N, Hoffman L, Gilger E, Gallagher M, Driver L, Meister D, Ward H, Drissi R, Kumar SS, Sengupta S, Kikta B, Meriwether W, Jelinek S, Asher A, Jones B, Leach J, Miles L, Fuller C, Fouladi M. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. J Neurooncol. 2021 Mar; 152: 107-114.
Martinez HR, Salloum R, Wright E, Bueche L, Khoury PR, Tretter JT, Ryan TD. Echocardiographic myocardial strain analysis describes subclinical cardiac dysfunction after craniospinal irradiation in pediatric and young adult patients with central nervous system tumors. Cardiooncology. 2021 Feb 2; 7: 5.
View More Publications
Research
Interests
Developmental Therapeutics Early Phase Clinical Trials Late Effects of CNS Tumors
Publications
Erker C, Mynarek M, Bailey S, Mazewski CM, Baroni L, Massimino M, Hukin J, Aguilera D, Cappellano AM, Ramaswamy V, Lassaletta A, Perreault S, Kline CN, Rajagopal R, Michaiel G, Zapotocky M, Santa-Maria Lopez V, La Madrid AM, Cacciotti C, Sandler ES, Hoffman LM, Klawinski D, Khan S, Salloum R, Hoppmann AL, Larouche V, Dorris K, Toledano H, Gilheeney SW, Abdelbaki MS, Wilson B, Tsang DS, Knipstein J, Oren MY, Shah S, Murray JC, Ginn KF, Wang ZJ, Fleischhack G, Obrecht D, Tonn S, Harrod VL, Matheson K, Crooks B, Strother DR, Cohen KJ, Hansford JR, Mueller S, Margol A, Gajjar A, Dhall G, Finlay JL, Northcott PA, Rutkowski S, Clifford SC, Robinson G, Bouffet E, Lafay-Cousin L. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. J Clin Oncol. 2022 Dec 22; JCO2102968.
Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;
Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;
DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. Front Oncol. 2022; 12: 893855.
Ronsley R, Boué DR, Venkata LPR, Scott S, Shaikhouni A, Jones J, Schieffer KM, Cottrell CE, Mardis ER, Olshefski R, Salloum R, Miller KE. An unusual case of atypical teratoid/rhabdoid tumor, initially diagnosed as atypical pituitary adenoma in a 13-year-old male patient. Neurooncol Adv. 2022 Jan-Dec; 4: vdac121.
Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.
Fisher AP, Patronick J, Gerhardt CA, Radonovich K, Salloum R, Wade SL. Impact of COVID-19 on adolescent and emerging adult brain tumor survivors and their parents. Pediatr Blood Cancer. 2021 Sep; 68: e29116.
McGrady ME, Bredenberg DL, Danziger-Isakov L, Rios J, Frias O, West MY, Fisher P, Salloum R, Pressey JG, Norris RE. Active and Protected: Developing a "Safer Sex" Handout for Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2021 Jun; 10: 351-354.
Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.
Moscato EL, Fisher AP, Gies LM, Smith-Paine JM, Miley AE, Beebe DW, Quinton TL, Pai ALH, Salloum R, Wade SL. A Mixed-Methods Analysis of Family Perceptions of Neuropsychological Evaluation and Resources for Pediatric Brain Tumor Survivors. Arch Clin Neuropsychol. 2021 Mar 24;
DeWire M, Erker C, Hummel TR, Chow LML, de Blank P, Salloum R, Pillay-Smiley N, Hoffman L, Gilger E, Gallagher M, Driver L, Meister D, Ward H, Drissi R, Kumar SS, Sengupta S, Kikta B, Meriwether W, Jelinek S, Asher A, Jones B, Leach J, Miles L, Fuller C, Fouladi M. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. J Neurooncol. 2021 Mar; 152: 107-114.
Martinez HR, Salloum R, Wright E, Bueche L, Khoury PR, Tretter JT, Ryan TD. Echocardiographic myocardial strain analysis describes subclinical cardiac dysfunction after craniospinal irradiation in pediatric and young adult patients with central nervous system tumors. Cardiooncology. 2021 Feb 2; 7: 5.
View More Publications
Research
Interests
Developmental Therapeutics Early Phase Clinical Trials Late Effects of CNS Tumors
Publications
Erker C, Mynarek M, Bailey S, Mazewski CM, Baroni L, Massimino M, Hukin J, Aguilera D, Cappellano AM, Ramaswamy V, Lassaletta A, Perreault S, Kline CN, Rajagopal R, Michaiel G, Zapotocky M, Santa-Maria Lopez V, La Madrid AM, Cacciotti C, Sandler ES, Hoffman LM, Klawinski D, Khan S, Salloum R, Hoppmann AL, Larouche V, Dorris K, Toledano H, Gilheeney SW, Abdelbaki MS, Wilson B, Tsang DS, Knipstein J, Oren MY, Shah S, Murray JC, Ginn KF, Wang ZJ, Fleischhack G, Obrecht D, Tonn S, Harrod VL, Matheson K, Crooks B, Strother DR, Cohen KJ, Hansford JR, Mueller S, Margol A, Gajjar A, Dhall G, Finlay JL, Northcott PA, Rutkowski S, Clifford SC, Robinson G, Bouffet E, Lafay-Cousin L. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. J Clin Oncol. 2022 Dec 22; JCO2102968.
Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;
Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;
DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. Front Oncol. 2022; 12: 893855.
Ronsley R, Boué DR, Venkata LPR, Scott S, Shaikhouni A, Jones J, Schieffer KM, Cottrell CE, Mardis ER, Olshefski R, Salloum R, Miller KE. An unusual case of atypical teratoid/rhabdoid tumor, initially diagnosed as atypical pituitary adenoma in a 13-year-old male patient. Neurooncol Adv. 2022 Jan-Dec; 4: vdac121.
Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.
Fisher AP, Patronick J, Gerhardt CA, Radonovich K, Salloum R, Wade SL. Impact of COVID-19 on adolescent and emerging adult brain tumor survivors and their parents. Pediatr Blood Cancer. 2021 Sep; 68: e29116.
McGrady ME, Bredenberg DL, Danziger-Isakov L, Rios J, Frias O, West MY, Fisher P, Salloum R, Pressey JG, Norris RE. Active and Protected: Developing a "Safer Sex" Handout for Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2021 Jun; 10: 351-354.
Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.
Moscato EL, Fisher AP, Gies LM, Smith-Paine JM, Miley AE, Beebe DW, Quinton TL, Pai ALH, Salloum R, Wade SL. A Mixed-Methods Analysis of Family Perceptions of Neuropsychological Evaluation and Resources for Pediatric Brain Tumor Survivors. Arch Clin Neuropsychol. 2021 Mar 24;
DeWire M, Erker C, Hummel TR, Chow LML, de Blank P, Salloum R, Pillay-Smiley N, Hoffman L, Gilger E, Gallagher M, Driver L, Meister D, Ward H, Drissi R, Kumar SS, Sengupta S, Kikta B, Meriwether W, Jelinek S, Asher A, Jones B, Leach J, Miles L, Fuller C, Fouladi M. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. J Neurooncol. 2021 Mar; 152: 107-114.
Martinez HR, Salloum R, Wright E, Bueche L, Khoury PR, Tretter JT, Ryan TD. Echocardiographic myocardial strain analysis describes subclinical cardiac dysfunction after craniospinal irradiation in pediatric and young adult patients with central nervous system tumors. Cardiooncology. 2021 Feb 2; 7: 5.
View More Publications
Interests
Developmental Therapeutics Early Phase Clinical Trials Late Effects of CNS Tumors
Publications
Erker C, Mynarek M, Bailey S, Mazewski CM, Baroni L, Massimino M, Hukin J, Aguilera D, Cappellano AM, Ramaswamy V, Lassaletta A, Perreault S, Kline CN, Rajagopal R, Michaiel G, Zapotocky M, Santa-Maria Lopez V, La Madrid AM, Cacciotti C, Sandler ES, Hoffman LM, Klawinski D, Khan S, Salloum R, Hoppmann AL, Larouche V, Dorris K, Toledano H, Gilheeney SW, Abdelbaki MS, Wilson B, Tsang DS, Knipstein J, Oren MY, Shah S, Murray JC, Ginn KF, Wang ZJ, Fleischhack G, Obrecht D, Tonn S, Harrod VL, Matheson K, Crooks B, Strother DR, Cohen KJ, Hansford JR, Mueller S, Margol A, Gajjar A, Dhall G, Finlay JL, Northcott PA, Rutkowski S, Clifford SC, Robinson G, Bouffet E, Lafay-Cousin L. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. J Clin Oncol. 2022 Dec 22; JCO2102968.
Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;
Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;
DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. Front Oncol. 2022; 12: 893855.
Ronsley R, Boué DR, Venkata LPR, Scott S, Shaikhouni A, Jones J, Schieffer KM, Cottrell CE, Mardis ER, Olshefski R, Salloum R, Miller KE. An unusual case of atypical teratoid/rhabdoid tumor, initially diagnosed as atypical pituitary adenoma in a 13-year-old male patient. Neurooncol Adv. 2022 Jan-Dec; 4: vdac121.
Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.
Fisher AP, Patronick J, Gerhardt CA, Radonovich K, Salloum R, Wade SL. Impact of COVID-19 on adolescent and emerging adult brain tumor survivors and their parents. Pediatr Blood Cancer. 2021 Sep; 68: e29116.
McGrady ME, Bredenberg DL, Danziger-Isakov L, Rios J, Frias O, West MY, Fisher P, Salloum R, Pressey JG, Norris RE. Active and Protected: Developing a "Safer Sex" Handout for Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2021 Jun; 10: 351-354.
Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.
Moscato EL, Fisher AP, Gies LM, Smith-Paine JM, Miley AE, Beebe DW, Quinton TL, Pai ALH, Salloum R, Wade SL. A Mixed-Methods Analysis of Family Perceptions of Neuropsychological Evaluation and Resources for Pediatric Brain Tumor Survivors. Arch Clin Neuropsychol. 2021 Mar 24;
DeWire M, Erker C, Hummel TR, Chow LML, de Blank P, Salloum R, Pillay-Smiley N, Hoffman L, Gilger E, Gallagher M, Driver L, Meister D, Ward H, Drissi R, Kumar SS, Sengupta S, Kikta B, Meriwether W, Jelinek S, Asher A, Jones B, Leach J, Miles L, Fuller C, Fouladi M. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. J Neurooncol. 2021 Mar; 152: 107-114.
Martinez HR, Salloum R, Wright E, Bueche L, Khoury PR, Tretter JT, Ryan TD. Echocardiographic myocardial strain analysis describes subclinical cardiac dysfunction after craniospinal irradiation in pediatric and young adult patients with central nervous system tumors. Cardiooncology. 2021 Feb 2; 7: 5.
View More Publications
Interests
Developmental Therapeutics Early Phase Clinical Trials Late Effects of CNS Tumors
Erker C, Mynarek M, Bailey S, Mazewski CM, Baroni L, Massimino M, Hukin J, Aguilera D, Cappellano AM, Ramaswamy V, Lassaletta A, Perreault S, Kline CN, Rajagopal R, Michaiel G, Zapotocky M, Santa-Maria Lopez V, La Madrid AM, Cacciotti C, Sandler ES, Hoffman LM, Klawinski D, Khan S, Salloum R, Hoppmann AL, Larouche V, Dorris K, Toledano H, Gilheeney SW, Abdelbaki MS, Wilson B, Tsang DS, Knipstein J, Oren MY, Shah S, Murray JC, Ginn KF, Wang ZJ, Fleischhack G, Obrecht D, Tonn S, Harrod VL, Matheson K, Crooks B, Strother DR, Cohen KJ, Hansford JR, Mueller S, Margol A, Gajjar A, Dhall G, Finlay JL, Northcott PA, Rutkowski S, Clifford SC, Robinson G, Bouffet E, Lafay-Cousin L. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. J Clin Oncol. 2022 Dec 22; JCO2102968.
Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;
Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;
DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. Front Oncol. 2022; 12: 893855.
Ronsley R, Boué DR, Venkata LPR, Scott S, Shaikhouni A, Jones J, Schieffer KM, Cottrell CE, Mardis ER, Olshefski R, Salloum R, Miller KE. An unusual case of atypical teratoid/rhabdoid tumor, initially diagnosed as atypical pituitary adenoma in a 13-year-old male patient. Neurooncol Adv. 2022 Jan-Dec; 4: vdac121.
Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.
Fisher AP, Patronick J, Gerhardt CA, Radonovich K, Salloum R, Wade SL. Impact of COVID-19 on adolescent and emerging adult brain tumor survivors and their parents. Pediatr Blood Cancer. 2021 Sep; 68: e29116.
McGrady ME, Bredenberg DL, Danziger-Isakov L, Rios J, Frias O, West MY, Fisher P, Salloum R, Pressey JG, Norris RE. Active and Protected: Developing a "Safer Sex" Handout for Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2021 Jun; 10: 351-354.
Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.
Moscato EL, Fisher AP, Gies LM, Smith-Paine JM, Miley AE, Beebe DW, Quinton TL, Pai ALH, Salloum R, Wade SL. A Mixed-Methods Analysis of Family Perceptions of Neuropsychological Evaluation and Resources for Pediatric Brain Tumor Survivors. Arch Clin Neuropsychol. 2021 Mar 24;
DeWire M, Erker C, Hummel TR, Chow LML, de Blank P, Salloum R, Pillay-Smiley N, Hoffman L, Gilger E, Gallagher M, Driver L, Meister D, Ward H, Drissi R, Kumar SS, Sengupta S, Kikta B, Meriwether W, Jelinek S, Asher A, Jones B, Leach J, Miles L, Fuller C, Fouladi M. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. J Neurooncol. 2021 Mar; 152: 107-114.
Martinez HR, Salloum R, Wright E, Bueche L, Khoury PR, Tretter JT, Ryan TD. Echocardiographic myocardial strain analysis describes subclinical cardiac dysfunction after craniospinal irradiation in pediatric and young adult patients with central nervous system tumors. Cardiooncology. 2021 Feb 2; 7: 5.
View More Publications
Interests
Developmental Therapeutics Early Phase Clinical Trials Late Effects of CNS Tumors
Developmental Therapeutics
Early Phase Clinical Trials
Late Effects of CNS Tumors
Erker C, Mynarek M, Bailey S, Mazewski CM, Baroni L, Massimino M, Hukin J, Aguilera D, Cappellano AM, Ramaswamy V, Lassaletta A, Perreault S, Kline CN, Rajagopal R, Michaiel G, Zapotocky M, Santa-Maria Lopez V, La Madrid AM, Cacciotti C, Sandler ES, Hoffman LM, Klawinski D, Khan S, Salloum R, Hoppmann AL, Larouche V, Dorris K, Toledano H, Gilheeney SW, Abdelbaki MS, Wilson B, Tsang DS, Knipstein J, Oren MY, Shah S, Murray JC, Ginn KF, Wang ZJ, Fleischhack G, Obrecht D, Tonn S, Harrod VL, Matheson K, Crooks B, Strother DR, Cohen KJ, Hansford JR, Mueller S, Margol A, Gajjar A, Dhall G, Finlay JL, Northcott PA, Rutkowski S, Clifford SC, Robinson G, Bouffet E, Lafay-Cousin L. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. J Clin Oncol. 2022 Dec 22; JCO2102968.
Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;
Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;
DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. Front Oncol. 2022; 12: 893855.
Ronsley R, Boué DR, Venkata LPR, Scott S, Shaikhouni A, Jones J, Schieffer KM, Cottrell CE, Mardis ER, Olshefski R, Salloum R, Miller KE. An unusual case of atypical teratoid/rhabdoid tumor, initially diagnosed as atypical pituitary adenoma in a 13-year-old male patient. Neurooncol Adv. 2022 Jan-Dec; 4: vdac121.
Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.
Fisher AP, Patronick J, Gerhardt CA, Radonovich K, Salloum R, Wade SL. Impact of COVID-19 on adolescent and emerging adult brain tumor survivors and their parents. Pediatr Blood Cancer. 2021 Sep; 68: e29116.
McGrady ME, Bredenberg DL, Danziger-Isakov L, Rios J, Frias O, West MY, Fisher P, Salloum R, Pressey JG, Norris RE. Active and Protected: Developing a “Safer Sex” Handout for Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2021 Jun; 10: 351-354.
Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.
Moscato EL, Fisher AP, Gies LM, Smith-Paine JM, Miley AE, Beebe DW, Quinton TL, Pai ALH, Salloum R, Wade SL. A Mixed-Methods Analysis of Family Perceptions of Neuropsychological Evaluation and Resources for Pediatric Brain Tumor Survivors. Arch Clin Neuropsychol. 2021 Mar 24;
DeWire M, Erker C, Hummel TR, Chow LML, de Blank P, Salloum R, Pillay-Smiley N, Hoffman L, Gilger E, Gallagher M, Driver L, Meister D, Ward H, Drissi R, Kumar SS, Sengupta S, Kikta B, Meriwether W, Jelinek S, Asher A, Jones B, Leach J, Miles L, Fuller C, Fouladi M. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. J Neurooncol. 2021 Mar; 152: 107-114.
Martinez HR, Salloum R, Wright E, Bueche L, Khoury PR, Tretter JT, Ryan TD. Echocardiographic myocardial strain analysis describes subclinical cardiac dysfunction after craniospinal irradiation in pediatric and young adult patients with central nervous system tumors. Cardiooncology. 2021 Feb 2; 7: 5.
Education
Date of Appointment at Nationwide Children’s Hospital: 11/09/2020
Board Certifications
Internal Medicine Pediatric Hematology Oncology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2015
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2014
Residency
Detroit Medical Center
Date Completed: 06/15/2011
Medical School
American University of Beruit
Date Completed: 06/09/2006
Education
Date of Appointment at Nationwide Children’s Hospital: 11/09/2020
Board Certifications
Internal Medicine Pediatric Hematology Oncology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2015
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2014
Residency
Detroit Medical Center
Date Completed: 06/15/2011
Medical School
American University of Beruit
Date Completed: 06/09/2006
Education
Date of Appointment at Nationwide Children’s Hospital: 11/09/2020
Board Certifications
Internal Medicine Pediatric Hematology Oncology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2015
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2014
Residency
Detroit Medical Center
Date Completed: 06/15/2011
Medical School
American University of Beruit
Date Completed: 06/09/2006
Date of Appointment at Nationwide Children’s Hospital: 11/09/2020
Board Certifications
Internal Medicine Pediatric Hematology Oncology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2015
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2014
Residency
Detroit Medical Center
Date Completed: 06/15/2011
Medical School
American University of Beruit
Date Completed: 06/09/2006
Date of Appointment at Nationwide Children’s Hospital: 11/09/2020
Board Certifications
Internal Medicine Pediatric Hematology Oncology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2015
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2014
Residency
Detroit Medical Center
Date Completed: 06/15/2011
Medical School
American University of Beruit
Date Completed: 06/09/2006
- Internal Medicine
- Pediatric Hematology Oncology
- Pediatrics
Clinical Interests
Adolescent and Young Adult Oncology Brain Tumor Survivorship Pediatric Neuro-oncology
Clinical Interests
Adolescent and Young Adult Oncology Brain Tumor Survivorship Pediatric Neuro-oncology
Clinical Interests
Adolescent and Young Adult Oncology Brain Tumor Survivorship Pediatric Neuro-oncology
Adolescent and Young Adult Oncology Brain Tumor Survivorship Pediatric Neuro-oncology
- Adolescent and Young Adult Oncology
- Brain Tumor Survivorship
- Pediatric Neuro-oncology
Contact Information
Pediatrics
Call us at: (614) 722-3250
Fax us at: (614) 722-8826
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-3250
Fax us at: (614) 722-8826
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-3250
Fax us at: (614) 722-8826
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Pediatrics
Call us at: (614) 722-3250
Fax us at: (614) 722-8826
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-3250
Fax us at: (614) 722-8826
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-3250
Fax us at: (614) 722-8826
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
- Call us at:
- (614) 722-3250
- Fax us at:
- (614) 722-8826
- Hematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
